{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:09:18Z","timestamp":1762524558076,"version":"build-2065373602"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"French Ministry of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09187-w","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:09:16Z","timestamp":1762520956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Arnaud","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-2057","authenticated-orcid":false,"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Bozec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Merckl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"3","key":"9187_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/tri.12218","volume":"27","author":"D Farrugia","year":"2014","unstructured":"Farrugia D, et al. Death within the first year after kidney transplantation\u2013an observational cohort study. Transpl Int. 2014;27(3):262\u201370.","journal-title":"Transpl Int"},{"issue":"10","key":"9187_CR2","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/j.1600-6143.2004.00573.x","volume":"4","author":"HU Meier-Kriesche","year":"2004","unstructured":"Meier-Kriesche HU, et al. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004;4(10):1662\u20138.","journal-title":"Am J Transplant"},{"issue":"8","key":"9187_CR3","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/TP.0000000000000660","volume":"99","author":"DO Dahle","year":"2015","unstructured":"Dahle DO, et al. Aortic stiffness in a mortality risk calculator for kidney transplant recipients. Transplantation. 2015;99(8):1730\u20137.","journal-title":"Transplantation"},{"issue":"9","key":"9187_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139138","volume":"10","author":"HS Kim","year":"2015","unstructured":"Kim HS, et al. Clinical significance of pre-transplant arterial stiffness and the impact of kidney transplantation on arterial stiffness. PLoS One. 2015;10(9):e0139138.","journal-title":"PLoS One"},{"issue":"4","key":"9187_CR5","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/j.1523-1755.2004.00912.x","volume":"66","author":"SA Bahous","year":"2004","unstructured":"Bahous SA, et al. Aortic pulse wave velocity in renal transplant patients. Kidney Int. 2004;66(4):1486\u201392.","journal-title":"Kidney Int"},{"issue":"10","key":"9187_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/tri.12151","volume":"26","author":"KJ Claes","year":"2013","unstructured":"Claes KJ, et al. Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipients. Transpl Int. 2013;26(10):973\u201381.","journal-title":"Transpl Int"},{"key":"9187_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007235","author":"A Sidibe","year":"2017","unstructured":"Sidibe A, et al. Reduction of arterial stiffness after kidney transplantation: a systematic review and meta-analysis. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.117.007235.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"9187_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1399-0012.2008.00794.x","volume":"22","author":"K Keven","year":"2008","unstructured":"Keven K, et al. Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index. Clin Transplant. 2008;22(3):360\u20135.","journal-title":"Clin Transplant"},{"issue":"1","key":"9187_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/HJH.0b013e32833f5e68","volume":"29","author":"S Ignace","year":"2011","unstructured":"Ignace S, et al. Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation. J Hypertens. 2011;29(1):130\u20136.","journal-title":"J Hypertens"},{"issue":"3","key":"9187_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.transproceed.2011.11.016","volume":"44","author":"K Hotta","year":"2012","unstructured":"Hotta K, et al. Successful kidney transplantation ameliorates arterial stiffness in end-stage renal disease patients. Transplant Proc. 2012;44(3):684\u20136.","journal-title":"Transplant Proc"},{"issue":"1","key":"9187_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10157-012-0653-z","volume":"17","author":"M Kaur","year":"2013","unstructured":"Kaur M, et al. Reduction in augmentation index after successful renal transplantation. Clin Exp Nephrol. 2013;17(1):134\u20139.","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"9187_CR12","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1016\/j.transproceed.2013.10.010","volume":"45","author":"D Kovacs","year":"2013","unstructured":"Kovacs D, et al. Noninvasive perioperative monitoring of arterial function in patients with kidney transplantation. Transplant Proc. 2013;45(10):3682\u20134.","journal-title":"Transplant Proc"},{"issue":"3","key":"9187_CR13","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.transproceed.2015.12.080","volume":"48","author":"H Ro","year":"2016","unstructured":"Ro H, et al. Can kidney transplantation improve arterial stiffness in end-stage renal patients? Transplant Proc. 2016;48(3):884\u20136.","journal-title":"Transplant Proc"},{"issue":"7","key":"9187_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00467-010-1509-y","volume":"25","author":"B Aoun","year":"2010","unstructured":"Aoun B, et al. Aortic stiffness in ESRD children before and after renal transplantation. Pediatr Nephrol. 2010;25(7):1331\u20136.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"9187_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12659\/AOT.881992","volume":"16","author":"P Strozecki","year":"2011","unstructured":"Strozecki P, et al. Progressive arterial stiffening in kidney transplant recipients. Ann Transplant. 2011;16(3):30\u20135.","journal-title":"Ann Transplant"},{"issue":"6","key":"9187_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","volume":"7","author":"F Vincenti","year":"2007","unstructured":"Vincenti F, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007;7(6):1506\u201314.","journal-title":"Am J Transplant"},{"issue":"3","key":"9187_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ckj\/sfx120","volume":"11","author":"E Melilli","year":"2018","unstructured":"Melilli E, et al. Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same? Clin Kidney J. 2018;11(3):413\u201321.","journal-title":"Clin Kidney J"},{"issue":"11","key":"9187_CR18","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1097\/HJH.0b013e32830ef940","volume":"26","author":"J Seckinger","year":"2008","unstructured":"Seckinger J, et al. Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens. 2008;26(11):2213\u20139.","journal-title":"J Hypertens"},{"issue":"11","key":"9187_CR19","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1111\/j.1600-6143.2011.03697.x","volume":"11","author":"R Joannides","year":"2011","unstructured":"Joannides R, et al. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant. 2011;11(11):2414\u201322.","journal-title":"Am J Transplant"},{"issue":"2","key":"9187_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ki.2015.312","volume":"89","author":"CA Amador","year":"2016","unstructured":"Amador CA, et al. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney Int. 2016;89(2):354\u201362.","journal-title":"Kidney Int"},{"key":"9187_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051373","author":"SM Figueroa","year":"2023","unstructured":"Figueroa SM, et al. The mineralocorticoid receptor on smooth muscle cells promotes tacrolimus-induced renal injury in mice. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15051373.","journal-title":"Pharmaceutics"},{"issue":"9931","key":"9187_CR22","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","volume":"383","author":"A Ortiz","year":"2014","unstructured":"Ortiz A, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831\u201343.","journal-title":"Lancet"},{"issue":"5","key":"9187_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/ndt\/gfz053","volume":"34","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, et al. Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant. 2019;34(5):760\u201373.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"9187_CR24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/HJH.0000000000002058","volume":"37","author":"MP Desjardins","year":"2019","unstructured":"Desjardins MP, et al. Impact of kidney transplantation on aortic stiffness and aortic stiffness index beta0. J Hypertens. 2019;37(7):1521\u20138.","journal-title":"J Hypertens"},{"issue":"4","key":"9187_CR25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1681\/ASN.2007060634","volume":"19","author":"M Delahousse","year":"2008","unstructured":"Delahousse M, et al. Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol. 2008;19(4):798\u2013805.","journal-title":"J Am Soc Nephrol"},{"key":"9187_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.981838","volume":"9","author":"A Elezaby","year":"2022","unstructured":"Elezaby A, Dexheimer R, Sallam K. Cardiovascular effects of immunosuppression agents. Front Cardiovasc Med. 2022;9:981838.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"9187_CR27","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jacc.2005.07.037","volume":"46","author":"CM McEniery","year":"2005","unstructured":"McEniery CM, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9187_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/pr.115.011106","volume":"68","author":"F Jaisser","year":"2016","unstructured":"Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology. Pharmacol Rev. 2016;68(1):49\u201375.","journal-title":"Pharmacol Rev"},{"issue":"10","key":"9187_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709\u201317.","journal-title":"N Engl J Med"},{"issue":"14","key":"9187_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309\u201321.","journal-title":"N Engl J Med"},{"issue":"7","key":"9187_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00392-018-1410-4","volume":"108","author":"KL Chin","year":"2019","unstructured":"Chin KL, et al. Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate. Clin Res Cardiol. 2019;108(7):806\u201314.","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"9187_CR32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/dom.12925","volume":"19","author":"SA de Boer","year":"2017","unstructured":"de Boer SA, et al. Effect of linagliptin on pulse wave velocity in early type 2 diabetes: a randomized, double-blind, controlled 26-week trial (RELEASE). Diabetes Obes Metab. 2017;19(8):1147\u201354.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"9187_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/01.CIR.82.1.105","volume":"82","author":"GM London","year":"1990","unstructured":"London GM, et al. Salt and water retention and calcium blockade in uremia. Circulation. 1990;82(1):105\u201313.","journal-title":"Circulation"},{"issue":"3","key":"9187_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1253\/circj.CJ-08-0492","volume":"73","author":"N Inoue","year":"2009","unstructured":"Inoue N, et al. Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly Japanese men. Circ J. 2009;73(3):549\u201353.","journal-title":"Circ J"},{"issue":"5","key":"9187_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","volume":"113","author":"T Willum-Hansen","year":"2006","unstructured":"Willum-Hansen T, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664\u201370.","journal-title":"Circulation"},{"issue":"5","key":"9187_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236\u201341.","journal-title":"Hypertension"},{"issue":"4","key":"9187_CR37","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938\u201342.","journal-title":"Hypertension"},{"issue":"10","key":"9187_CR38","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1681\/ASN.V12102117","volume":"12","author":"T Shoji","year":"2001","unstructured":"Shoji T, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001;12(10):2117\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"9187_CR39","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588\u2013605.","journal-title":"Eur Heart J"},{"issue":"4","key":"9187_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153635","volume":"11","author":"JP Bertocchio","year":"2016","unstructured":"Bertocchio JP, et al. Safety of eplerenone for kidney-transplant recipients with impaired renal function and receiving cyclosporine A. PLoS One. 2016;11(4):e0153635.","journal-title":"PLoS One"},{"issue":"8","key":"9187_CR41","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2215\/CJN.05300516","volume":"12","author":"M Medeiros","year":"2017","unstructured":"Medeiros M, et al. Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy. Clin J Am Soc Nephrol. 2017;12(8):1291\u2013300.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"9187_CR42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2215\/CJN.0000000000000439","volume":"19","author":"LA Mortensen","year":"2024","unstructured":"Mortensen LA, et al. Effect of spironolactone on kidney function in kidney transplant recipients (the SPIREN trial): a randomized placebo-controlled clinical trial. Clin J Am Soc Nephrol. 2024;19(6):755\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9187_CR43","doi-asserted-by":"publisher","first-page":"205435812090697","DOI":"10.1177\/2054358120906974","volume":"7","author":"RA Rodriguez","year":"2020","unstructured":"Rodriguez RA, et al. Pharmacologic therapies for aortic stiffness in end-stage renal disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2020;7:2054358120906974.","journal-title":"Can J Kidney Health Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09187-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:04:18Z","timestamp":1762524258000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09187-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9187"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09187-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has been approved by the French regulatory agency (Agence nationale de la s\u00e9curit\u00e9 du medicament et des produits de sant\u00e9: ANSM) and the appropriate ethics committee (Comit\u00e9 de Protection des Personnes: CPP). Written informed consent will be obtained from all participants by investigators.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final submitted version of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FJ received a research grant from Bayer and AstraZeneca. NG received honoraria from AstraZeneca, Bayer, Boehringer, Lilly, Novo Nordisk, Novartis, and Roche Diagnostics. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}